Third stage
(2017)
Begin to start the generation of leadership alternation, build a research and development platform with technical barriers.
In 2018, Qingfeng innovation incubator launched to operation. In 2019, Sales reaches 5 billion. Organization adjusted for focusing on innovation. In 2020, Preparing for IPO.
In 2001, Moved to industrial Park, the asset was reorganized and expand
In 2005, Establishing R&D center and marketing and commercializing system
In 2008, Establishing Qingfeng Pharma Group with Investment outreach
In 2010, Establishing multi R&D platform, and acquire Shanghai Denovo. Sales exceeds 1 billion.
In 2016, Sales reaches 4 billion.Shanghai R&D headquarter established.
|